-
Who’s best supporting post-translational modifications?
In the data we’re releasing today we explore those antibody suppliers that are doing...November 16, 2016 -
Will you be at SfN this year?
We’re heading out to San Diego this week to join the Society for Neuroscience’s...November 10, 2016 -
CiteAb data boosts life science sales teams’ results
Here at CiteAb we’re delighted to be launching our first custom data for sales...November 3, 2016 -
Can you predict the top neuroscience antibody targets?
We’re just a few weeks out from the Society for Neuroscience’s annual event, so...October 26, 2016 -
GBSI-hosted antibody validation event outlines new approaches
Last week, our founder Dr Andrew Chalmers attended the Antibody Validation: Standards, Policies, and...October 7, 2016 -
New collaborations harness CiteAb data
Over the past month we’ve embarked on two new partnerships that will see CiteAb...October 4, 2016 -
Who is winning the market share race?
In the data we’re releasing today we take a look at which suppliers are...September 28, 2016 -
Catch up on AbVal16!
If you follow our blog regularly you couldn’t have missed that last week our...September 22, 2016 -
A proposal for the validation of antibodies
The International Working Group for Antibody Validation, which we have mentioned before here on...September 13, 2016 -
The CiteAb team is growing!
It has been a very busy year for us here at CiteAb – working...September 8, 2016 -
Want to succeed in the Western Blot antibody market?
Our latest data report focuses on how your company can succeed in the Western...August 24, 2016 -
Room for growth at Abcam?
As we approach the announcement of Abcam’s end of year results in September,...August 10, 2016
